Is Lenvatinib a targeted drug?

Lenvatinib is considered a targeted therapy, not a chemotherapy drug. Targeted cancer treatments work by affecting specific target molecules that cause cancer to grow and spread. Lenvatinib helps cancer survive by blocking cellular proteins and signals that target blood vessels. These types of drugs are often referred to as "precision medicine," and lenvatinib belongs to a class of drugs called vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitors (TKIs). Targeted therapies are specifically designed to interact with their targets rather than with all cells in general (although they may affect other cells and cause side effects).